AHLA's Speaking of Health Law AHLA Podcasts

Health systems are beginning to address the many issues that come with the physician enterprise. Rudd Kierstead, Director, Veralon, speaks with Victoria Sheridan, Counsel, Corporate & Regulatory Affairs, Atlantic Health System, about some of the motivating issues, key factors, and main goals related to integrating the physician enterprise. They also discuss issues related to governance and branding. Sponsored by Veralon. 
To learn more about AHLA and the educational resources available to the health law community, visit americanhealthlaw.org.

Jackie Papish, Partner, Barnes & Thornburg LLP, and Peter Dressel, Senior Managing Director, FTI Consulting, discuss Medicare outlier payments in the health care industry and how providers can navigate issues related to fraud, waste, and abuse. They cover what outliers are in the health care context, how the government deals with outliers from a reimbursement perspective, a history of outlier payment government enforcement, and how providers can deal with outlier payments that are the focus of a government fraud and abuse investigation. Sponsored by Stout. 
To learn more about AHLA and the educational resources available to the health law community, visit americanhealthlaw.org.

Lori Foley, Office Managing Principal, PYA, speaks with Jay Dewald, Partner, Norton Rose Fulbright, about recent trends and developments related to health care acquisitions. They discuss the Biden Administration’s approach to private equity in health care, diligence and the impact of government payers, examples of Travel Act indictments, state approaches to private equity, and key takeaways related to diligence. Sponsored by PYA.
To learn more about AHLA and the educational resources available to the health law community, visit americanhealthlaw.org.

Lisa Gora, Partner, Epstein Becker Green, and Richard Cheng, Managing Member, Ritter Spencer Cheng, discuss the burgeoning area of psychedelics in the health care industry. They cover some of the driving forces behind the resurging interest in psychedelics, federal and state developments, the contravention between state and federal law, and the future of the psychedelics industry and potential regulatory and legal shifts. Sponsored by Stout.
To learn more about AHLA and the educational resources available to the health law community, visit americanhealthlaw.org.

Andrew Ruskin, Partner, K&L Gates LLP, speaks with Mary Edmondson, Chief Compliance Officer, Inova Health, about the aftermath of last year’s Supreme Court decision in the SuperValu case and how health care organizations can prepare for potential investigations. They discuss how to ensure that stakeholders in an organization feel comfortable raising questions with compliance, how to evaluate whether a current practice is lawful, lessons learned from the Christiana case, and how to demonstrate reasonable steps related to compliance with the 60-day repayment rule.
To learn more about AHLA and the educational resources available to the health law community, visit americanhealthlaw.org.

Michelle Frazier, Chief Compliance and Privacy Officer, Advocate Health, and David Glaser, Shareholder, Fredrikson & Byron, discuss how to mitigate risk using regulatory requirements and guidance. They cover the distinction between law and guidance, the legal authority to support that distinction and how to reconcile that distinction when being proactive about mitigating risk, real world examples of where these distinctions matter, strategies for hiring compliance positions, and the overlap between compliance and legal. Sponsored by Stout. 
To learn more about AHLA and the educational resources available to the health law community, visit americanhealthlaw.org.